Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cough-relief Loquat Granules (Zhike Pipa Keli) is a Traditional Chinese Medicine (TCM) formulation developed and marketed by Shanghai Kaibao Xinyi. It is primarily used as an antitussive and expectorant to treat coughs associated with bronchitis and the common cold. The formulation typically includes botanical extracts such as Loquat leaf (*Eriobotrya japonica*), Mulberry bark (*Morus alba*), and Platycodon root (*Platycodon grandiflorus*), which work synergistically to clear heat from the lungs, resolve phlegm, and suppress cough. It is administered orally in a granule dosage form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhike pipa keli.